Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID® with Cipla Biotech Investing
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S. Pharmaceutical Investing
Gilead Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast Cancer Biotech Investing
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine Pharmaceutical Investing
RINVOQ Achieved Superiority Versus DUPIXENT® For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis Biotech Investing
Gilead Announces Racial Equity Community Impact Fund to Support Black Communities Across United States Biotech Investing
Upadacitinib ) Meets Primary and All Ranked Secondary Endpoints in First Phase 3 Induction Study in Ulcerative Colitis Biotech Investing
